share_log

Amylyx Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.8%),TCG Crossover Fund II, L.P.(6.8%), etc.

SEC ·  Aug 26 17:51
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more